Sintx Technologies (SINT) Asset Writedowns and Impairment (2013 - 2026)
Sintx Technologies' (SINT) quarterly Asset Writedowns and Impairment came in at $9000.0 in Q1 2026, down 85.94% year-on-year from $64000.0 in Q1 2025, and down 86.15% quarter-over-quarter from $65000.0 in Q4 2025.
Sintx Technologies (SINT) Asset Writedowns and Impairment (2013 - 2026) Analysis & Trends
Sintx Technologies' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $9000.0 for Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 85.94% year-over-year to $9000.0 in Q1 2026; TTM through Mar 2026 was $9000.0, a 99.81% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 98.61% from the prior year.
- Asset Writedowns and Impairment fell to $9000.0 in Q1 2026 per SINT's latest filing, from $65000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $4.5 million in Q3 2024 and bottomed at -$67000.0 in Q2 2025.
- The 5-year median for Asset Writedowns and Impairment is $9000.0 (2026), against an average of $427818.2.
- Across the five-year window, Asset Writedowns and Impairment soared 1333.33% in 2024 and sank 99.96% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$5000.0 in 2022, then surged by 40.0% to -$3000.0 in 2023, then soared by 4933.33% to $145000.0 in 2024, then plunged by 55.17% to $65000.0 in 2025, then slumped by 86.15% to $9000.0 in 2026.
- Per Business Quant, the three latest SINT Asset Writedowns and Impairment figures stand at $9000.0 (Q1 2026), $65000.0 (Q4 2025), and $2000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Sintx Technologies | 5.80 Mn | 3.91 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Sep 30, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Mar 31, 2023 | -3,000.00 |